BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32072743)

  • 1. Determination of HIV status and identification of incident HIV infections in a large, community-randomized trial: HPTN 071 (PopART).
    Eshleman SH; Piwowar-Manning E; Wilson EA; Lennon D; Fogel JM; Agyei Y; Sullivan PA; Weng L; Moore A; Laeyendecker O; Kosloff B; Bwalya J; Maarman G; van Deventer A; Floyd S; Bock P; Ayles H; Fidler S; Hayes R; Donnell D;
    J Int AIDS Soc; 2020 Feb; 23(2):e25452. PubMed ID: 32072743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: A cross-sectional survey (TREATS).
    Klinkenberg E; Floyd S; Shanaube K; Mureithi L; Gachie T; de Haas P; Kosloff B; Dodd PJ; Ruperez M; Wapamesa C; Burnett JM; Kalisvaart N; Kasese N; Vermaak R; Schaap A; Fidler S; Hayes R; Ayles H;
    PLoS Med; 2023 Sep; 20(9):e1004278. PubMed ID: 37682971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-related stigma and universal testing and treatment for HIV prevention and care: design of an implementation science evaluation nested in the HPTN 071 (PopART) cluster-randomized trial in Zambia and South Africa.
    Hargreaves JR; Stangl A; Bond V; Hoddinott G; Krishnaratne S; Mathema H; Moyo M; Viljoen L; Brady L; Sievwright K; Horn L; Sabapathy K; Ayles H; Beyers N; Bock P; Fidler S; Griffith S; Seeley J; Hayes R;
    Health Policy Plan; 2016 Dec; 31(10):1342-1354. PubMed ID: 27375126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding low sensitivity of community-based HIV rapid testing: experiences from the HPTN 071 (PopART) trial in Zambia and South Africa.
    Bock P; Phiri C; Piwowar-Manning E; Kosloff B; Mandla N; Young A; James A; Schaap A; Scheepers M; Donnell D; Griffith S; El-Sadr W; Shanaube K; Beyers N; Hayes R; Fidler S; Ayles H;
    J Int AIDS Soc; 2017 Aug; 20(Suppl 6):21780. PubMed ID: 28872272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV testing and treatment coverage achieved after 4 years across 14 urban and peri-urban communities in Zambia and South Africa: An analysis of findings from the HPTN 071 (PopART) trial.
    Floyd S; Shanaube K; Yang B; Schaap A; Griffith S; Phiri M; Macleod D; Sloot R; Sabapathy K; Bond V; Bock P; Ayles H; Fidler S; Hayes R;
    PLoS Med; 2020 Apr; 17(4):e1003067. PubMed ID: 32240156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment - a study protocol for a cluster randomised trial.
    Hayes R; Ayles H; Beyers N; Sabapathy K; Floyd S; Shanaube K; Bock P; Griffith S; Moore A; Watson-Jones D; Fraser C; Vermund SH; Fidler S;
    Trials; 2014 Feb; 15():57. PubMed ID: 24524229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-level analysis of natural control of HIV infection in Zambia and South Africa: HPTN 071 (PopART).
    Grant-McAuley W; Piwowar-Manning E; Clarke W; Breaud A; Zewdie KB; Moore A; Ayles HM; Kosloff B; Shanaube K; Bock P; Meehan SA; Maarman G; Fidler S; Hayes R; Donnell D; Eshleman SH;
    J Int AIDS Soc; 2023 Oct; 26(10):e26179. PubMed ID: 37886843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial.
    Thomas R; Probert WJM; Sauter R; Mwenge L; Singh S; Kanema S; Vanqa N; Harper A; Burger R; Cori A; Pickles M; Bell-Mandla N; Yang B; Bwalya J; Phiri M; Shanaube K; Floyd S; Donnell D; Bock P; Ayles H; Fidler S; Hayes RJ; Fraser C; Hauck K;
    Lancet Glob Health; 2021 May; 9(5):e668-e680. PubMed ID: 33721566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Universal Testing and Treatment on HIV Incidence - HPTN 071 (PopART).
    Hayes RJ; Donnell D; Floyd S; Mandla N; Bwalya J; Sabapathy K; Yang B; Phiri M; Schaap A; Eshleman SH; Piwowar-Manning E; Kosloff B; James A; Skalland T; Wilson E; Emel L; Macleod D; Dunbar R; Simwinga M; Makola N; Bond V; Hoddinott G; Moore A; Griffith S; Deshmane Sista N; Vermund SH; El-Sadr W; Burns DN; Hargreaves JR; Hauck K; Fraser C; Shanaube K; Bock P; Beyers N; Ayles H; Fidler S;
    N Engl J Med; 2019 Jul; 381(3):207-218. PubMed ID: 31314965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can combination prevention strategies reduce HIV transmission in generalized epidemic settings in Africa? The HPTN 071 (PopART) study plan in South Africa and Zambia.
    Vermund SH; Fidler SJ; Ayles H; Beyers N; Hayes RJ
    J Acquir Immune Defic Syndr; 2013 Jul; 63 Suppl 2(0 2):S221-7. PubMed ID: 23764639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.
    Hayes R; Floyd S; Schaap A; Shanaube K; Bock P; Sabapathy K; Griffith S; Donnell D; Piwowar-Manning E; El-Sadr W; Beyers N; Ayles H; Fidler S;
    PLoS Med; 2017 May; 14(5):e1002292. PubMed ID: 28464041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPTN 071 (PopART): a cluster-randomized trial of the population impact of an HIV combination prevention intervention including universal testing and treatment: mathematical model.
    Cori A; Ayles H; Beyers N; Schaap A; Floyd S; Sabapathy K; Eaton JW; Hauck K; Smith P; Griffith S; Moore A; Donnell D; Vermund SH; Fidler S; Hayes R; Fraser C;
    PLoS One; 2014; 9(1):e84511. PubMed ID: 24454728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards 90-90: Findings after two years of the HPTN 071 (PopART) cluster-randomized trial of a universal testing-and-treatment intervention in Zambia.
    Floyd S; Ayles H; Schaap A; Shanaube K; MacLeod D; Phiri M; Griffith S; Bock P; Beyers N; Fidler S; Hayes R;
    PLoS One; 2018; 13(8):e0197904. PubMed ID: 30096139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of self-reported tuberculosis treatment with community-wide universal testing and treatment for HIV and tuberculosis screening in Zambia and South Africa: A planned analysis of the HPTN 071 (PopART) cluster-randomised trial.
    Telisinghe L; Floyd S; MacLeod D; Schaap A; Dunbar R; Bwalya J; Bell-Mandla N; Piwowar-Manning E; Donnell D; Shaunaube K; Bock P; Fidler S; Hayes RJ; Ayles HM;
    PLoS Med; 2024 May; 21(5):e1004393. PubMed ID: 38820246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What works - reaching universal HIV testing: lessons from HPTN 071 (PopART) trial in Zambia.
    Shanaube K; Schaap A; Floyd S; Phiri M; Griffith S; Chaila J; Bock P; Hayes R; Fidler S; Ayles H;
    AIDS; 2017 Jul; 31(11):1555-1564. PubMed ID: 28471766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of timely linkage-to-ART within universal test and treat in the HPTN 071 (PopART) trial in Zambia and South Africa: findings from a nested case-control study.
    Sabapathy K; Mubekapi-Musadaidzwa C; Mulubwa C; Schaap A; Hoddinott G; Stangl A; Floyd S; Ayles H; Fidler S; Hayes R;
    J Int AIDS Soc; 2017 Dec; 20(4):. PubMed ID: 29251433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2: a prespecified secondary outcomes analysis of the HPTN 071 (PopART) community-randomised trial.
    Wilson E; Donnell D; Skalland T; Floyd S; Moore A; Bell-Mandla N; Bwalya J; Kasese N; Dunbar R; Shanaube K; Kosloff B; Laeyendecker O; Agyei Y; Hoddinott G; Bock P; Fidler S; Hayes R; Ayles H;
    Lancet HIV; 2022 Nov; 9(11):e760-e770. PubMed ID: 36332653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of a screening tool to aid home-based identification of adolescents (aged 10-14) living with HIV in Zambia and South Africa: HPTN 071 (PopART) study.
    Chaila MJ; Mcleod D; Vermund SH; Mbolongwe-Thornicroft M; Mbewe M; Mubekapi-Musadaidzwa C; Harper A; Schaap A; Floyd S; Hoddinott G; Hayes R; Fidler S; Ayles H; Shanaube K;
    PLoS One; 2024; 19(2):e0266573. PubMed ID: 38363733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysis.
    Macleod D; Shanaube K; Skalland T; Limbada M; Mandla N; Bwalya J; Schaap A; Yang B; Donnell D; Piwowar-Manning E; Eshleman SH; Hoddinott G; Bond V; Moore A; Griffith S; Bock P; Ayles H; Fidler S; Hayes R; Floyd S;
    Lancet HIV; 2022 Nov; 9(11):e751-e759. PubMed ID: 36332652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between HIV stigma and HIV incidence in the context of universal testing and treatment: analysis of data from the HPTN 071 (PopART) trial in Zambia and South Africa.
    Hargreaves JR; Pliakas T; Hoddinott G; Mainga T; Mubekapi-Musadaidzwa C; Donnell D; Wilson E; Piwowar-Manning E; Agyei Y; Bell-Mandla NF; Dunbar R; Schaap A; Macleod D; Floyd S; Bock P; Fidler S; Seeley J; Stangl A; Bond V; Ayles H; Hayes RJ;
    J Int AIDS Soc; 2022 Jul; 25 Suppl 1(Suppl 1):e25931. PubMed ID: 35818869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.